Scientific and regulatory evaluation of empirical pharmacometric models: An application of the risk informed credibility assessment framework
Abstract Empirical pharmacometric models are part of practically every regulatory submission for a new drug. The use of the models often exceeds descriptory roles and this change in their context of use increase the requirements on the evidence to support that they are credible. However, when it com...
Enregistré dans:
Auteurs principaux: | Ine Skottheim Rusten, Flora Tshinanu Musuamba |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/22f9226774ba4d07af13a0fb0501d239 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility
par: Flora T. Musuamba, et autres
Publié: (2021) -
Metaheuristics for pharmacometrics
par: Seongho Kim, et autres
Publié: (2021) -
Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy
par: Michael A. Tortorici, et autres
Publié: (2021) -
Pharmacometric analyses of alectinib to facilitate approval of the optimal dose for the first‐line treatment of anaplastic lymphoma kinase–positive non‐small cell lung cancer
par: Joy C. Hsu, et autres
Publié: (2021) -
Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
par: Rena Eudy‐Byrne, et autres
Publié: (2021)